New research from Griffith University has shown that a bacterium commonly present in the nose…
Browsing: Alzheimer’s Disease
Alzheimer’s disease is a progressive neurodegenerative disorder that is the most common cause of dementia, affecting memory, thinking, and behavior. It typically begins with mild memory loss and gradually worsens, eventually interfering with daily tasks and cognitive function. Characterized by the buildup of abnormal protein deposits—amyloid plaques and tau tangles—in the brain, Alzheimer’s is currently incurable, though research is rapidly evolving. Ongoing scientific studies are exploring its causes, early detection methods, genetic risk factors, and potential treatments, with the goal of better understanding and ultimately halting or reversing the disease.
Amyloid beta, a protein known to build-up in the brains of Alzheimer’s patients, also helps…
Dementia patients struggle with changes due to damage in brain networks vital for recognizing new…
A European consortium coordinated by UNIGE shows how a mutation in the APOE protein changes…
Researchers have discovered that follicle-stimulating hormone (FSH) plays a critical role in the development of…
Higher physical fitness lowers the risk of Alzheimer’s, with the most fit individuals being 33%…
A study found a genetic link between depression and Alzheimer’s, suggesting that depression may accelerate…
Ability of immune system to destroy Alzheimer’s-related protein oscillates with daily circadian rhythm. The brain’s…
Retinal thickness could serve as an early marker for Alzheimer’s, allowing optical scans to predict…
A study reveals that immune cells clearing amyloid-beta in Alzheimer’s patients are influenced by circadian…
Recent research reveals that COVID-19 patients show higher short-term levels of brain injury markers than…
Research suggests that cognitive decline in older adults doesn’t always indicate Alzheimer’s disease, with studies…
Physical activity in the elderly is linked to increased levels of proteins that improve neural…
Osaka City University’s new study reveals that a nasal spray mix of rifampicin and resveratrol…
A study conducted at the University of Helsinki and the Helsinki University Hospital suggests that…
Scripps Research Discovery Illuminates How Brain Cells Die in Prion Diseases Researchers show how toxic…
Boosting norepinephrine reduces neuroinflammation markers in MCI. Boosting levels of the neurotransmitter norepinephrine with atomoxetine,…
Chemical’s release in brain tied to processing of imagery, cells’ activation. “Look at me!” we…